Tucatinib

본문 바로가기


Home > Product > Tucatinib
Selling leads
Tucatinib
Posting date : Jun 30, 2025
Membership
Free Member Scince Jun 27, 2025
FOB Price
detailed discussion
Min. Order Quantity
1
Supply Abillity
hundreds of kgs
Port
Shanghai Port
Payment Terms
detailed discussion
Package
Convenient package
Keyword :
Category
Contact
Lena
Selling Leads Detail
Company Info
 
Quick Detail
Place of Origin
China [CN]
Brand Name
Royal
Model Number
+86 15242851296
HS-CODE
-
Package & Delivery Lead Time
Package
Convenient package
Detailed Description

Tukysa (Tucatinib)/Tucatinib (ONT-380) is an oral TKI(tyrosine kinase) inhibitor with high specificity for HER2. On April 17, 2020, the US FDA approved the combination of tucatinib with trastuzumab and capecitabine. It is used for the treatment of adult patients with treatable advanced HER2-positive breast cancer that cannot be resected by surgery or has metastases


ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us
Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea
About Us Privacy Policy Terms of use Copyright © 2000-2026 ECROBOT.COM. All rights reserved.
Top